Interleukin 22 disrupts pancreatic function in newborn mice expressing IL-23.
Clicks: 282
ID: 57733
2019
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Steady Performance
30.0
/100
281 views
17 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Neonatal inflammatory diseases are associated with severe morbidity, but the inflammatory factors underlying them and their potential effector mechanisms are poorly defined. Here we show that necrotizing enterocolitis in neonate mice is accompanied by elevation of IL-23 and IL-22 and decreased production of pancreatic enzymes. These phenotypes are mirrored in neonate mice overexpressing IL-23 in CX3CR1 myeloid cells or in keratinocytes. The mice fail to grow and die prematurely, displaying systemic inflammation, nutrient malabsorption and decreased expression of intestinal and pancreatic genes mediating digestion and absorption of carbohydrates, proteins, and lipids. Germ-free environment improves, and genetic ablation of IL-22 restores normal growth in mice overexpressing IL-23. Mechanistically, IL-22 acts directly at the level of pancreatic acinar cells to decrease expression of the pancreas associated transcription factor 1a (PTF1a). These results show that augmented production of IL-23 and IL-22 in early life has a negative impact on pancreatic enzyme secretion and food absorption.
| Reference Key |
chen2019interleukinnature
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Chen, Lili;Strohmeier, Valentina;He, Zhengxiang;Deshpande, Madhura;Catalan-Dibene, Jovani;Durum, Scott K;Moran, Thomas M;Kraus, Thomas;Xiong, Huabao;Faith, Jeremiah J;Sodhi, Chhinder P;Hackam, David J;Lira, Sergio A;Furtado, Glaucia C; |
| Journal | Nature communications |
| Year | 2019 |
| DOI |
10.1038/s41467-019-12540-8
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.